Magnoflorine

CAS No. 2141-09-5

Magnoflorine( Magnoflorine | α-Magnoflorine | Thalictrine )

Catalog No. M17720 CAS No. 2141-09-5

Sinomeni Caulis et Rhizoma has sedative and anxiolytic effects, probably mediated by Magnoflorine through a GABAergic mechanism of action.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 261 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Magnoflorine
  • Note
    Research use only, not for human use.
  • Brief Description
    Sinomeni Caulis et Rhizoma has sedative and anxiolytic effects, probably mediated by Magnoflorine through a GABAergic mechanism of action.
  • Description
    Sinomeni Caulis et Rhizoma has sedative and anxiolytic effects, probably mediated by Magnoflorine through a GABAergic mechanism of action. Magnoflorine and Sinomenine have protective effects, are mediated by some mechanism other than prevention of micelle formation or protection of the erythrocyte membrane against osmotic imbalance.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Magnoflorine | α-Magnoflorine | Thalictrine
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    c-Myc
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    2141-09-5
  • Formula Weight
    342.41
  • Molecular Formula
    C20H24NO4+
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[N+]1(CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)OC)O)O)OC)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Stauprimide

    A staurosporine analog that promotes embryonic stem cell (ESC) differentiation by inhibiting nuclear localization of the MYC transcription factor NME2.

  • MYC inhibitor DC-34

    MYC inhibitor DC-34 is a potent small molecule that selectively inhibits MYC at the transcriptional level only when a G-quadruplex (G4) is present in the promoter.

  • KJ-Pyr-9

    KJ-Pyr-9 is a novel small-molecule inhibitor of c-Myc (Kd=6.5 ± 1.0 nM).